Navigation Links
InterMune Announces Issuance of U.S. Patent for ITMN-191
Date:2/19/2009

BRISBANE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced the issuance of U.S. Patent Number 7,491,794, a composition of matter patent which covers the ITMN-191 (R7227) compound. The nominal 20-year patent term extends to October 13, 2024. ITMN-191 is an inhibitor of the hepatitis C virus (HCV) NS3/4A protease.

Dan Welch, Chairman, Chief Executive Officer and President of InterMune, said, "We are pleased to announce that this new patent, which is the foundation of our intellectual property coverage of ITMN-191, has issued. We look forward to continued progress in developing ITMN-191 with our partner, Roche, as we anticipate the start of our Phase 2b program in the second quarter of 2009."

About ITMN-191 (R7227)

ITMN-191 is being developed with InterMune's collaborative partner, Roche, for the treatment of patients chronically infected with HCV. On January 12, 2009, InterMune announced top-line results from a 14-day study of ITMN-191 in combination with Pegasys(R) (peginterferon alfa-2a) and Copegus(R) (ribavirin). InterMune reported that after 14 days of triple combination therapy, the median change in HCV RNA from baseline exceeded 5 log10 in five of the six dosage cohorts in the study, and was -5.4 log10 and -5.7 log10 in the best performing q12h and q8h cohorts, respectively. Reductions in HCV RNA occurred rapidly and there was no evidence of viral rebound during ITMN-191 treatment in any cohort. ITMN-191 was generally safe and well tolerated in the study. There were no serious adverse events or Grade 4 adverse events (AEs) during treatment with ITMN-191. AEs reported during study treatment (ITMN-191 or placebo) were predominantly mild to moderate in severity, typically consistent with the AE profile of standard of care (SOC), and none led to trea
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 Virobay, Inc. today announced that ... reached an important milestone, as Virobay has now initiated ... selective cathepsin S inhibitor.   The first ... placebo-controlled study designed to evaluate the safety, tolerability, pharmacokinetics ... adults. "The initiation of this Phase 1 ...
(Date:5/23/2013)... Northwest Biotherapeutics (NASDAQ: NWBO ) ... personalized immune therapies for solid tumor cancers, announced today ... American Society Of Clinical Oncology (ASCO) meeting in ... in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ) ... pre-eminent conference focused on clinical treatment of cancer, with ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 During ... is critical to adhere to principles of good ... , Esteemed speaker Dr. Jeremy Lim, Fellow, Clinical ... , ,     Understand the International Conference ... (GCP) and additional regulations for the conduction of ...
(Date:5/23/2013)... Chicago, IL (PRWEB) May 23, 2013 Bed ... battle against the pests is still ongoing, a report from ... thousands more for the bed bug treatment. Meanwhile, to be ... an apartment from the costly bed bug exterminator ... 2013, stated that AHA has so far spent ...
Breaking Biology Technology:Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2Bed Bug Exterminator Service Could Cost AHA $250K, My Cleaning Products Gives Tips How to Save Apartments from Costly Bed Bug Treatment 2
... , , IMAP APPLICATION ... By Liz Gaudet, Ph.D., Joyce Itatani, Francisco, Ramirez and Annegret Boge, ... , INTRODUCTION ... drug discovery. Many suppliers offer a profiling, ...
... , , IONWORKS HT APPLICATION NOTE #4 , ... Chen, Ph.D., Jinfang Liao, Ph.D., , Jeff Quast, Andrew Wittel, ... Corporation, 3280 Whipple Road, Union City, CA 94587., INTRODUCTION ... largely untapped portion of the potential drug, ...
... , ... , ... Application Guide ........................................................................................................................2 , ... ................................................................................................................................2 , ...
Cached Biology Technology:Setting up a kinase profiler with IMAP 2Setting up a kinase profiler with IMAP 3Setting up a kinase profiler with IMAP 4Setting up a kinase profiler with IMAP 5Setting up a kinase profiler with IMAP 6Setting up a kinase profiler with IMAP 7Setting up a kinase profiler with IMAP 8Setting up a kinase profiler with IMAP 9Setting up a kinase profiler with IMAP 10Setting up a kinase profiler with IMAP 11Setting up a kinase profiler with IMAP 12Setting up a kinase profiler with IMAP 13Setting up a kinase profiler with IMAP 14Setting up a kinase profiler with IMAP 15Setting up a kinase profiler with IMAP 16Setting up a kinase profiler with IMAP 17Setting up a kinase profiler with IMAP 18Setting up a kinase profiler with IMAP 19Setting up a kinase profiler with IMAP 20Setting up a kinase profiler with IMAP 21Setting up a kinase profiler with IMAP 22Setting up a kinase profiler with IMAP 23Setting up a kinase profiler with IMAP 24Setting up a kinase profiler with IMAP 25Setting up a kinase profiler with IMAP 26Setting up a kinase profiler with IMAP 27Setting up a kinase profiler with IMAP 28Setting up a kinase profiler with IMAP 29Setting up a kinase profiler with IMAP 30Setting up a kinase profiler with IMAP 31Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 2Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 3Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 4Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 5Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 6
(Date:5/21/2013)... Using a "patient monitoring" device attached to a whale ... time how fishing lines changed a whale,s diving and ... whales, ability to eat and migrate, depletes their energy ... can result in a slow death. , The scientists ... a Dtag to a two-year-old female North Atlantic right ...
(Date:5/21/2013)... USC have found that a class of pharmaceuticals can ... , The drugs, known as "TSPO ligands," are currently ... at the effects of TSPO ligand in young adult ... in aged mice when pathology was quite severe," said ... of Gerontology. "TSPO ligand reduced measures of pathology and ...
(Date:5/21/2013)... available in pharmacies and health stores, phosphatidylserine is ... and soy. Proven to improve cognition and slow ... people experiencing memory impairment. Now a team headed ... of Tel Aviv University,s Department of Human ... supplement improves the functioning of genes involved in ...
Breaking Biology News(10 mins):Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3Drugs found to both prevent and treat Alzheimer's disease in mice 2Common food supplement fights degenerative brain disorders 2
... 10 October 2008.- During the 1950s, Austrian and Swiss ... Nepal taking photographs of the glaciers, mountains and valleys. ... spent eight months in the region at locations above ... , Now, fifty years later, the black and white ...
... From Local to Global, will be the focus of ... this single event is just one small step in ... around the world and requires immediate attention in order ... and deficiencies. The Society for Nutrition Education (SNE) encourages ...
... Pregnancy and motherhood may make us all go a little ... to mental health researchers at The Australian National University. ... Research (CMHR) at ANU suggests that despite fears mothers ... no evidence to suggest that is true. The findings have ...
Cached Biology News:'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 3World Food Day brings attention to food security around the globe 2Pregnancy not turning minds to mush: Study 2
... in this kit are prepared with pure ... Biochains Mitochondria Isolation Kit is designed to ... fast and easy way. One kit is ... isolations (enriching mitochondria from 10 20 ...
... plasmid DNA preparations are prepared from ... from 1mg to multi-gram scales. ... (100mg-multi-gram) preparations are made according to ... formulated according to customer needs, and ...
... hormones which belong to the transforming ... superfamily is a large group of ... aspects of development, reproductive function and ... TGF-s, bone morphogenetic proteins, growth differentiation ...
... GST•Tag™ Antibody Plate is a 96-well ... Antibody. This antibody (mouse IgG 1 ... japonicum glutathione-S-transferase (GST), and binds ... GST•Tag fusion protein in which the ...
Biology Products: